A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
Prins, Niels D, Harrison, John E, Chu, Hui-May, Blackburn, Kelly, Alam, John J, Scheltens, Philip, Rowell, Zarate, Norden, Van
Published in Alzheimer's research & therapy (27.05.2021)
Published in Alzheimer's research & therapy (27.05.2021)
Get full text
Journal Article